Drug Discovery and Development Analysis & Statistics, November 2012 (p50)

24/7 Customer Support

Talk to Louis

+44 20 3286 0679

1471-1500 of about 1 700 reports

Purchase Reports From Reputable Market Research Publishers

Triple Analysis: Pancreatic Cancer, Apoptosis and Antibodies

Triple Analysis: Pancreatic Cancer, Apoptosis and Antibodies

  • € 3 450
  • Company report
  • November 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Pancreatic Cancer), one mechanism/target/effect area (Apoptosis) and one compound specific area (Antibodies). ...

  • Industries : Drug and Medication, Pathology, Pharmaceutical, Drug Discovery and Development, General Medicine and Specialty Medicine
Triple Analysis: Pancreatic Cancer, Angiogenesis and Antibodies

Triple Analysis: Pancreatic Cancer, Angiogenesis and Antibodies

  • € 3 450
  • Company report
  • November 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Pancreatic Cancer), one mechanism/target/effect area (Angiogenesis) and one compound specific area ...

  • Industries : Drug and Medication, Pathology, Pharmaceutical, Drug Discovery and Development, General Medicine and Specialty Medicine
Triple Analysis: Pancreatic Cancer, Protein Kinase Inhibitors and Antibodies

Triple Analysis: Pancreatic Cancer, Protein Kinase Inhibitors and Antibodies

  • € 3 450
  • Company report
  • November 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Pancreatic Cancer), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific ...

  • Industries : Drug and Medication, Pharmaceutical, Pathology, Drug Discovery and Development, General Medicine and Specialty Medicine
Triple Analysis: Colorectal Cancer, Leukemia and Antibodies

Triple Analysis: Colorectal Cancer, Leukemia and Antibodies

  • € 3 450
  • Company report
  • November 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Leukemia and by the compound strategy of Antibodies. Each of these three individual parts is evaluated according ...

  • Industries : Pathology, Pharmaceutical, Drug and Medication, Drug Discovery and Development
Triple Analysis: Colorectal Cancer, Lung Cancer and Antibodies

Triple Analysis: Colorectal Cancer, Lung Cancer and Antibodies

  • € 3 450
  • Company report
  • November 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Lung Cancer and by the compound strategy of Antibodies. Each of these three individual parts is evaluated ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Pharmaceutical, Drug and Medication, Drug Discovery and Development
Triple Analysis: Colorectal Cancer, Lymphoma and Antibodies

Triple Analysis: Colorectal Cancer, Lymphoma and Antibodies

  • € 3 450
  • Company report
  • November 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Lymphoma and by the compound strategy of Antibodies. Each of these three individual parts is evaluated according ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Pharmaceutical, Drug and Medication, Drug Discovery and Development
Triple Analysis: Colorectal Cancer, Apoptosis and Antibodies

Triple Analysis: Colorectal Cancer, Apoptosis and Antibodies

  • € 3 450
  • Company report
  • November 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Colorectal Cancer), one mechanism/target/effect area (Apoptosis) and one compound specific area (Antibodies). ...

  • Industries : Drug and Medication, Pathology, Pharmaceutical, Drug Discovery and Development, General Medicine and Specialty Medicine
Triple Analysis: Colorectal Cancer, Angiogenesis and Antibodies

Triple Analysis: Colorectal Cancer, Angiogenesis and Antibodies

  • € 3 450
  • Company report
  • November 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Colorectal Cancer), one mechanism/target/effect area (Angiogenesis) and one compound specific area ...

  • Industries : Drug and Medication, Pathology, Pharmaceutical, Drug Discovery and Development, General Medicine and Specialty Medicine
Triple Analysis: Colorectal Cancer, Protein Kinase Inhibitors and Antibodies

Triple Analysis: Colorectal Cancer, Protein Kinase Inhibitors and Antibodies

  • € 3 450
  • Company report
  • November 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Colorectal Cancer), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific ...

  • Industries : Drug and Medication, Pharmaceutical, Pathology, Drug Discovery and Development, General Medicine and Specialty Medicine
Triple Analysis: Leukemia, Lung Cancer and Antibodies

Triple Analysis: Leukemia, Lung Cancer and Antibodies

  • € 3 450
  • Company report
  • November 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Leukemia and Lung Cancer and by the compound strategy of Antibodies. Each of these three individual parts is evaluated according ...

  • Industries : Pathology, Pharmaceutical, Drug and Medication, Drug Discovery and Development
Triple Analysis: Leukemia, Lymphoma and Antibodies

Triple Analysis: Leukemia, Lymphoma and Antibodies

  • € 3 450
  • Company report
  • November 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Leukemia and Lymphoma and by the compound strategy of Antibodies. Each of these three individual parts is evaluated according ...

  • Industries : Pathology, Pharmaceutical, Drug and Medication, Drug Discovery and Development
Triple Analysis: Leukemia, Apoptosis and Antibodies

Triple Analysis: Leukemia, Apoptosis and Antibodies

  • € 3 450
  • Company report
  • November 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Leukemia), one mechanism/target/effect area (Apoptosis) and one compound specific area (Antibodies). ...

  • Industries : Drug and Medication, Pathology, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Leukemia, Angiogenesis and Antibodies

Triple Analysis: Leukemia, Angiogenesis and Antibodies

  • € 3 450
  • Company report
  • November 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Leukemia), one mechanism/target/effect area (Angiogenesis) and one compound specific area (Antibodies). ...

  • Industries : Drug and Medication, Pathology, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Leukemia, Protein Kinase Inhibitors and Antibodies

Triple Analysis: Leukemia, Protein Kinase Inhibitors and Antibodies

  • € 3 450
  • Company report
  • November 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Leukemia), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific area ...

  • Industries : Drug and Medication, Pharmaceutical, Pathology, Drug Discovery and Development
Triple Analysis: Lung Cancer, Lymphoma and Antibodies

Triple Analysis: Lung Cancer, Lymphoma and Antibodies

  • € 3 450
  • Company report
  • November 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Lymphoma and by the compound strategy of Antibodies. Each of these three individual parts is evaluated according ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Pharmaceutical, Drug and Medication, Drug Discovery and Development
Pathways to Efficient Drug Development - Advances in Modeling and Simulation Outcomes to Fuel Pipeline Productivity

Pathways to Efficient Drug Development - Advances in Modeling and Simulation Outcomes to Fuel Pipeline Productivity

  • € 2 800
  • Industry report
  • September 2012
  • by GBI Research

Pathways to Efficient Drug Development - Advances in Modeling and Simulation Outcomes to Fuel Pipeline Productivity Summary GBI Research, the leading business intelligence provider, has released its latest ...

  • Industries : Drug Discovery and Development
Accelerating Drugs to Market - Despite Challenges, Adaptive Clinical Trials Reduce Drug Development Costs and Time to Market

Accelerating Drugs to Market - Despite Challenges, Adaptive Clinical Trials Reduce Drug Development Costs and Time to Market

  • € 2 800
  • Industry report
  • September 2012
  • by GBI Research

Accelerating Drugs to Market - Despite Challenges, Adaptive Clinical Trials Reduce Drug Development Costs and Time to Market Summary GBI Research’s new report, “Accelerating Drugs to Market - Despite ...

  • Industries : Drug Discovery and Development
US Cancer Vaccine Market Analysis

US Cancer Vaccine Market Analysis

  • € 960
  • Industry report
  • September 2012
  • by RNCOS

Cancer vaccines are highly researched today owing to growing cancer incidences and an urgent need to control and prevent the massively penetrating disease. Amongst the highest incident cancers, prostate ...

  • Industries : Biopharmaceutical, Drug and Medication, Pharmaceutical, Biotechnology, Pathology
  • Countries : United States, World
Triple Analysis: Lung Cancer, Pancreatic Cancer and Prostate Cancer

Triple Analysis: Lung Cancer, Pancreatic Cancer and Prostate Cancer

  • € 3 450
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Lung Cancer, Pancreatic Cancer and Prostate Cancer. Each of these three individual parts is evaluated according to standardized criteria ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Pharmaceutical, Drug and Medication, Drug Discovery and Development
Triple Analysis: Lung Cancer, Prostate Cancer and Apoptosis

Triple Analysis: Lung Cancer, Prostate Cancer and Apoptosis

  • € 3 450
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Prostate Cancer and by the mechanism/target/effect of Apoptosis. Each of these three individual parts is evaluated ...

  • Industries : General Medicine and Specialty Medicine, Drug and Medication, Pathology, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Lung Cancer, Prostate Cancer and Angiogenesis

Triple Analysis: Lung Cancer, Prostate Cancer and Angiogenesis

  • € 3 450
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Prostate Cancer and by the mechanism/target/effect of Angiogenesis. Each of these three individual parts is evaluated ...

  • Industries : General Medicine and Specialty Medicine, Drug and Medication, Pathology, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Lung Cancer, Prostate Cancer and Protein Kinase Inhibitors

Triple Analysis: Lung Cancer, Prostate Cancer and Protein Kinase Inhibitors

  • € 3 450
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Prostate Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual ...

  • Industries : General Medicine and Specialty Medicine, Drug and Medication, Pathology, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Lymphoma, Pancreatic Cancer and Prostate Cancer

Triple Analysis: Lymphoma, Pancreatic Cancer and Prostate Cancer

  • € 3 450
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Lymphoma, Pancreatic Cancer and Prostate Cancer. Each of these three individual parts is evaluated according to standardized criteria ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Pharmaceutical, Drug and Medication
Triple Analysis: Lymphoma, Prostate Cancer and Apoptosis

Triple Analysis: Lymphoma, Prostate Cancer and Apoptosis

  • € 3 450
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Lymphoma and Prostate Cancer and by the mechanism/target/effect of Apoptosis. Each of these three individual parts is evaluated ...

  • Industries : General Medicine and Specialty Medicine, Pathology, Drug and Medication, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Lymphoma, Prostate Cancer and Angiogenesis

Triple Analysis: Lymphoma, Prostate Cancer and Angiogenesis

  • € 3 450
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Lymphoma and Prostate Cancer and by the mechanism/target/effect of Angiogenesis. Each of these three individual parts is evaluated ...

  • Industries : General Medicine and Specialty Medicine, Pathology, Drug and Medication, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Lymphoma, Prostate Cancer and Protein Kinase Inhibitors

Triple Analysis: Lymphoma, Prostate Cancer and Protein Kinase Inhibitors

  • € 3 450
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Lymphoma and Prostate Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual parts ...

  • Industries : General Medicine and Specialty Medicine, Pathology, Drug and Medication, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Pancreatic Cancer, Prostate Cancer and Apoptosis

Triple Analysis: Pancreatic Cancer, Prostate Cancer and Apoptosis

  • € 3 450
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Pancreatic Cancer and Prostate Cancer and by the mechanism/target/effect of Apoptosis. Each of these three individual parts is ...

  • Industries : Drug and Medication, General Medicine and Specialty Medicine, Pathology, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Pancreatic Cancer, Prostate Cancer and Angiogenesis

Triple Analysis: Pancreatic Cancer, Prostate Cancer and Angiogenesis

  • € 3 450
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Pancreatic Cancer and Prostate Cancer and by the mechanism/target/effect of Angiogenesis. Each of these three individual parts ...

  • Industries : Drug and Medication, General Medicine and Specialty Medicine, Pathology, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Pancreatic Cancer, Prostate Cancer and Protein Kinase Inhibitors

Triple Analysis: Pancreatic Cancer, Prostate Cancer and Protein Kinase Inhibitors

  • € 3 450
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Pancreatic Cancer and Prostate Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual ...

  • Industries : General Medicine and Specialty Medicine, Drug and Medication, Pathology, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Prostate Cancer, Apoptosis and Angiogenesis

Triple Analysis: Prostate Cancer, Apoptosis and Angiogenesis

  • € 3 450
  • Company report
  • September 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Prostate Cancer and by the two mechanism/target/effect areas of Apoptosis and Angiogenesis. Each of these three individual parts is ...

  • Industries : Drug and Medication, Pharmaceutical, Drug Discovery and Development, General Medicine and Specialty Medicine

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.